Literature DB >> 14670131

Mechanisms underlying postmortem redistribution of drugs: a review.

Anne-Laure Pélissier-Alicot1, Jean-Michel Gaulier, Pierre Champsaur, Pierre Marquet.   

Abstract

Postmortem drug concentrations do not necessarily reflect concentrations at the time of death, as drug levels may vary according to the sampling site and the interval between death and specimen collection. These site- and time-dependent variations are called "postmortem redistribution" (PMR). The underlying mechanisms are complex and of different types. Passive drug release from drug reservoirs such as the gastrointestinal tract, liver, lungs, and myocardium may occur immediately after death and, later on, cell autolysis and the putrefactive process participate in redistribution. There is evidence that basic lipophilic drugs with a large distribution volume are particularly susceptible to PMR. Nevertheless, this cannot explain the actual PMR of some nonbasic, nonlipophilic drugs. In addition, the persistence of drug metabolism immediately after death must be considered. Consequently, it is of great importance to analyze specimens from different sampling sites in order to detect potential PMR and avoid misinterpretation of results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670131     DOI: 10.1093/jat/27.8.533

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  24 in total

1.  Can subclavian blood be equated with a peripheral blood sample? A series of 50 cases.

Authors:  Caroline Sastre; Valérie Baillif-Couniou; Faustine Musarella; Christophe Bartoli; Julien Mancini; Marie-Dominique Piercecchi-Marti; Georges Leonetti; Anne-Laure Pelissier-Alicot
Journal:  Int J Legal Med       Date:  2012-07-07       Impact factor: 2.686

2.  High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.

Authors:  Kei Zaitsu; Hiroshi Nakayama; Mayumi Yamanaka; Kazuaki Hisatsune; Kentaro Taki; Tomomi Asano; Tooru Kamata; Munehiro Katagai; Yumi Hayashi; Maiko Kusano; Hitoshi Tsuchihashi; Akira Ishii
Journal:  Int J Legal Med       Date:  2015-09-08       Impact factor: 2.686

Review 3.  Post-mortem clinical pharmacology.

Authors:  R E Ferner
Journal:  Br J Clin Pharmacol       Date:  2008-05-29       Impact factor: 4.335

4.  The effect of the postmortem interval on the redistribution of drugs: a comparison of mortuary admission and autopsy blood specimens.

Authors:  Dimitri Gerostamoulos; Jochen Beyer; Voula Staikos; Penny Tayler; Noel Woodford; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2012-05-22       Impact factor: 2.007

Review 5.  Liver and peripheral blood concentration ratio (L/P) as a marker of postmortem drug redistribution: a literature review.

Authors:  Iain M McIntyre
Journal:  Forensic Sci Med Pathol       Date:  2013-11-07       Impact factor: 2.007

6.  A suicide involving intraperitoneal injection of pentobarbital.

Authors:  Sarah Hangartner; Jasmin Steiner; Franz Dussy; Regula Moeckli; Kathrin Gerlach; Thomas Briellmann
Journal:  Int J Legal Med       Date:  2015-07-15       Impact factor: 2.686

Review 7.  Postmortem toxicology.

Authors:  Gisela Skopp
Journal:  Forensic Sci Med Pathol       Date:  2010-03-04       Impact factor: 2.007

8.  Quantitative determination of valproic acid in postmortem blood samples--evidence of strong matrix dependency and instability.

Authors:  Verena Kiencke; Hilke Andresen-Streichert; Alexander Müller; Stefanie Iwersen-Bergmann
Journal:  Int J Legal Med       Date:  2013-03-28       Impact factor: 2.686

9.  Postmortem redistribution of THC in the pig.

Authors:  Bertrand Brunet; Thierry Hauet; William Hébrard; Yves Papet; Gérard Mauco; Patrick Mura
Journal:  Int J Legal Med       Date:  2010-01-07       Impact factor: 2.686

10.  Fatal drug poisonings in a Swedish general population.

Authors:  Anna K Jönsson; Olav Spigset; Micaela Tjäderborn; Henrik Druid; Staffan Hägg
Journal:  BMC Clin Pharmacol       Date:  2009-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.